☰

Mona Khalaj - Publications

Affiliations: 
2011-2017 Memorial Sloan Kettering Cancer Center, Rockville Centre, NY, United States 
 2018- SCBRM Stanford University School of Medicine, Palo Alto, CA, United States 
Website:
https://profiles.stanford.edu/mona-khalaj
Tree Info Similar researchers PubMed Report error

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Stranahan AW, Berezniuk I, Chakraborty S, Feller F, Khalaj M, Park CY. Leukotrienes promote stem cell self-renewal and chemoresistance in acute myeloid leukemia. Leukemia. PMID 35461365 DOI: 10.1038/s41375-022-01579-0  0.657
2019 Rassouli H, Khalaj M, Hassani SN, Nemati SH, Hosseini Salekdeh GH, Baharvand H. Gene Expression Patterns of Royan Human Embryonic Stem Cells Correlate with Their Propensity and Culture Systems. Cell Journal. 21: 290-299. PMID 31210435 DOI: 10.22074/cellj.2019.6128  0.351
2018 Amin S, Cook B, Zhou T, Ghazizadeh Z, Lis R, Zhang T, Khalaj M, Crespo M, Perera M, Xiang JZ, Zhu Z, Tomishima M, Liu C, Naji A, Evans T, et al. Discovery of a drug candidate for GLIS3-associated diabetes. Nature Communications. 9: 2681. PMID 29992946 DOI: 10.1038/S41467-018-04918-X  0.313
2017 Khalaj M, Woolthuis CM, Hu W, Durham BH, Chu SH, Qamar S, Armstrong SA, Park CY. miR-99 regulates normal and malignant hematopoietic stem cell self-renewal. The Journal of Experimental Medicine. PMID 28733386 DOI: 10.1084/Jem.20161595  0.724
2017 Khalaj M, Park CY. snoRNAs contribute to myeloid leukaemogenesis. Nature Cell Biology. 19: 758-760. PMID 28659642 DOI: 10.1038/Ncb3566  0.626
2017 Chung SS, Eng WS, Hu W, Khalaj M, Garrett-Bakelman FE, Tavakkoli M, Levine RL, Carroll M, Klimek VM, Melnick AM, Park CY. CD99 is a therapeutic target on disease stem cells in myeloid malignancies. Science Translational Medicine. 9. PMID 28123069 DOI: 10.1126/Scitranslmed.Aaj2025  0.68
2016 Elias HK, Khalaj M, Park CY. Divergent roles of in normal and malignant stem cells. Translational Cancer Research. 5: S328-S331. PMID 33088733 DOI: 10.21037/tcr.2016.07.15  0.676
2016 Elias HK, Khalaj M, Park CY. Divergent roles of miR-126 in normal and malignant stem cells Translational Cancer Research. 5. DOI: 10.21037/8804  0.718
2016 Khalaj M, Woolthuis C, Hu W, Durham BH, Park CY. Mir-99 Regulates Normal and Leukemic Stem Cell Function Blood. 128: 1469-1469. DOI: 10.1182/Blood.V128.22.1469.1469  0.709
2015 Khalaj M, Hu W, Park CY. Mir-99 Is a Regulator of Hematopoietic and Leukemic Stem Cell Differentiation Blood. 126: 3063-3063. DOI: 10.1182/Blood.V126.23.3063.3063  0.72
2014 Khalaj M, Tavakkoli M, Stranahan AW, Park CY. Pathogenic microRNA's in myeloid malignancies. Frontiers in Genetics. 5: 361. PMID 25477897 DOI: 10.3389/Fgene.2014.00361  0.637
2014 Khalaj M, Park CY. Notch one up to stroma: endothelial notch prevents inflammation and myeloproliferation. Cell Stem Cell. 15: 1-2. PMID 24996160 DOI: 10.1016/J.Stem.2014.06.010  0.677
Show low-probability matches.